Sort

Search

01/01/2025 Predicting Hospitalisation In Older Patients Attended In The Emergency Department Using Classical And Aritficaiil Intelligence Mathematical Strategies
Aguirre, NL, Gutiérrez, SG, Miro, O, Jacob, J, Llorens, P, Burillo-Putze, G, Fernández, C, Alquezar-Arbé, A, Aguiló, S, Pérez, FJM, Bermejo, JJN, Vera, MTM, García, AG, Ezponda, P, Lorenzo, AM, Almela, AFS, Martin, JMS, Ramón, SS, Liarte, JVO, Diez, MAB, Puente, PH, Olagünaga, AM, Fernandez, EC, Molina, L, Juan, MM, Rodríguez, ED, del Castillo, JG. Predicting Hospitalisation In Older Patients Attended In The Emergency Department Using Classical And Aritficaiil Intelligence Mathematical Strategies. Journal Of Health Research. 2025; 39(3)DOI:10.56808/2586-940X.1141. PMID:. IF:(Q/D).
01/01/2025 Polysensitization in the Spanish Contact Dermatitis Registry (REIDAC): A 2019-2022 prospective study with cluster and network analysis
Pesqué, D, Borrego, L, Zaragoza-Ninet, V, Sanz-Sánchez, T, Miquel-Miquel, FJ, González-Pérez, R, Silvestre, JF, Córdoba-Guijarro, S, Carrascosa, JM, Gatica-Ortega, ME, Ruiz-González, I, Mercader-García, P, Tous-Romero, F, de Frutos, FJO, Serra-Baldrich, E, Pastor-Nieto, MA, Rodríguez-Serna, M, Sánchez-Pérez, J, Sánchez-Gilo, A, Melé-Ninot, G, Guillén, PSP, Pujol, RM, Giménez-Arnau, AM. Polysensitization in the Spanish Contact Dermatitis Registry (REIDAC): A 2019-2022 prospective study with cluster and network analysis. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY. 2025; 39(1)DOI:10.1111/jdv.19934. PMID:38411353. IF:8.000(Q1/1D).
01/01/2025 Real-world adalimumab survival and discontinuation factors in hidradenitis suppurativa
Garbayo-Salmons, P, Vilarrasa, E, Bassas-Vila, J, Mora-Fernández, V, Fuertes, I, Luque-Luna, M, Fornons-Servent, R, Martin-Ezquerra, G, Aguayo-Ortiz, RS, Ceravalls, J, Mollet, J, Tomás, AG, Masferrer, E, Corral-Magaña, O, Matas-Nadal, C, del Estal, J, Bailón, DF, Calvet, J, Romani, J. Real-world adalimumab survival and discontinuation factors in hidradenitis suppurativa. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY. 2025; 39(1)DOI:10.1111/jdv.20044. PMID:38687278. IF:8.000(Q1/1D).
01/01/2025 EFFECTIVENESS OF 12-MONTHS TRALOKINUMAB TREATMENT IN 124 ADULTS WITH ATOPIC DERMATITIS WITH GENITAL INVOLVEMENT: FINAL REAL-WORLD DATA FROM THE PROSPECTIVE, NON-INTERVENTIONAL, INTERNATIONAL, SINGLE-COHORT TRACE STUDY
Ameen, A, Serra-Baldrich, E, Arm-Strong, A, Festini, T, Vinther, F, Vittrup, I, Wiseman, MC. EFFECTIVENESS OF 12-MONTHS TRALOKINUMAB TREATMENT IN 124 ADULTS WITH ATOPIC DERMATITIS WITH GENITAL INVOLVEMENT: FINAL REAL-WORLD DATA FROM THE PROSPECTIVE, NON-INTERVENTIONAL, INTERNATIONAL, SINGLE-COHORT TRACE STUDY. ACTA DERMATO-VENEREOLOGICA. 2025; 105DOI:. PMID:. IF:3.700(Q1/2D).
01/01/2025 Introduction of the 10th World Symposium for Lymphedema Surgery
Cheng, MH, Chang, DW, Masia, J. Introduction of the 10th World Symposium for Lymphedema Surgery. JOURNAL OF SURGICAL ONCOLOGY. 2025; 131(1)DOI:10.1002/jso.27919. PMID:39387585. IF:1.900(Q2/4D).
01/01/2025 Reply to Letter Re: Metal Ion Release in Cancer Patients Following Megaprosthesis Salvage Surgery
Fa-Binefa, M, Rojas-Sayol, R. Reply to Letter Re: Metal Ion Release in Cancer Patients Following Megaprosthesis Salvage Surgery. JOURNAL OF ARTHROPLASTY. 2025; 40(1)DOI:10.1016/j.arth.2024.09.036. PMID:39615984. IF:3.800(Q1/2D).
01/01/2025 Differential diagnosis and comparison of diagnostic algorithms in children and adolescents with autoimmune encephalitis in Spain: a prospective cohort study and retrospective analysis
Olivé-Cirera, G, Fonseca, E, Chen, LW, Fetta, A, Martínez-Hernández, E, Guasp, M, González-Alvarez, V, Delgadillo, V, Cantarín-Extremera, V, Jiménez-Legido, M, Monge-Galindo, L, Felipe, A, Beseler, B, Turón-Viñas, E, Fernández-Ramos, J, Martínez-González, MJ, Vázquez-López, M, Fernandez, LA, Alvarez-Molinero, M, Muñoz-Cabello, B, Camacho, A, Nuñez-Enamorado, N, Spatola, M, Sabater, L, Blanco, Y, Saiz, A, Graus, F, Dalmau, J, Armangué, T. Differential diagnosis and comparison of diagnostic algorithms in children and adolescents with autoimmune encephalitis in Spain: a prospective cohort study and retrospective analysis. LANCET NEUROLOGY. 2025; 24(1)DOI:10.1016/S1474-4422(24)00443-5. PMID:39706634. IF:45.500(Q1/1D).
01/01/2025 Late gadolinium enhancement and outcome of cardiac resynchronization therapy in non-ischemic cardiomyopathy
Anguera, I, Faga, V, Jimenez-Candil, J, Moreno-Weidmann, Z, Santos-Ortega, A, Jimenez-Jaimez, J, Rodriguez-García, J, Claver, E, Meré, J, Jovells-Vaque, S, Diez-Lopez, C, Hernández, J, Rivas-Gandara, N, Macías, R, García-Cosculluela, D, Comin-Colet, J, Di Marco, A. Late gadolinium enhancement and outcome of cardiac resynchronization therapy in non-ischemic cardiomyopathy. INTERNATIONAL JOURNAL OF CARDIOLOGY. 2025; 418DOI:10.1016/j.ijcard.2024.132618. PMID:39384095. IF:3.200(Q2/3D).
01/01/2025 Validation of the Valve Academic Research Consortium High Bleeding Risk Definition in Patients Undergoing TAVR
Avvedimento, M, Cepas-Guillén, P, Ternacle, J, Urena, M, Alperi, A, Cheema, A, Veiga-Fernandez, G, Nombela-Franco, L, Vilalta, V, Esposito, G, Campelo-Parada, F, Indolfi, C, del Trigo, M, Muñoz-Garcia, A, Maneiro, N, Asmarats, L, Regueiro, A, del Val, D, Serra, V, Auffret, V, Modine, T, Bonnet, G, Mesnier, J, Suc, G, Avanzas, P, Rezaei, E, Fradejas-Sastre, V, Tirado-Conte, G, Fernández-Nofrerias, E, Franzone, A, Guitteny, T, Sorrentino, S, Oteo, JF, Nuche, J, Gutiérrez-Alonso, L, Flores-Umanzor, E, Alfonso, F, Monastyrski, A, Nolf, M, Côté, M, Mehran, R, Morice, MC, Capodanno, D, Garot, P, Rodés-Cabau, J. Validation of the Valve Academic Research Consortium High Bleeding Risk Definition in Patients Undergoing TAVR. Circulation-Cardiovascular Interventions. 2025; 18(1)DOI:10.1161/CIRCINTERVENTIONS.124.014800. PMID:39475194. IF:7.400(Q1/2D).
01/01/2025 Lipid-lowering therapy after acute coronary syndromes: a multinational European survey
Tsaban, G, Perez, RV, Krychtiuk, KA, Ahrens, I, Halvorsen, S, Hassager, C, Huber, K, Schiele, F, Sionis, A, Claeys, MJ. Lipid-lowering therapy after acute coronary syndromes: a multinational European survey. CORONARY ARTERY DISEASE. 2025; 36(1)DOI:10.1097/MCA.0000000000001420. PMID:39263716. IF:2.000(Q3/6D).
01/01/2025 Safety and Efficacy of the Use of pdVWF/FVIII-C in Patients with von Willebrand Disease: A Prospective, Observational, Post-Authorization Study
Hidalgo, OB, Alonso, CM, Jaime, FJL, Carrasco, M, Hernández, MDN, Afonso, N, Lei, A, Whyms, D, Hanna, K, Aragonés, ME, Torres, M, Oliveras, J. Safety and Efficacy of the Use of pdVWF/FVIII-C in Patients with von Willebrand Disease: A Prospective, Observational, Post-Authorization Study. CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS. 2025; 31DOI:10.1177/10760296251327593. PMID:40079811. IF:2.000(Q3/6D).
01/01/2025 Acquired FXIII Deficiency Secondary to a Myelodysplastic Syndrome
Vilalta, N, Oñate, G, Triquell, M, Carrasco, M, Mateo, J. Acquired FXIII Deficiency Secondary to a Myelodysplastic Syndrome. HAEMOPHILIA. 2025; 31DOI:. PMID:. IF:3.000(Q2/4D).
01/01/2025 Prospective View of Emicizumab Treatment According Thrombin Generation Time
Vilalta, N, Triquell, M, Llobet, D, Simón, M, Cerdà, N, Carrasco, M, Mateo, J. Prospective View of Emicizumab Treatment According Thrombin Generation Time. HAEMOPHILIA. 2025; 31DOI:. PMID:. IF:3.000(Q2/4D).
01/01/2025 Probiotics: A Potential Strategy for Preventing and Managing Cardiovascular Disease
López-Yerena, A, Villaplana, VD, Badimon, L, Vilahur, G, Padro, T. Probiotics: A Potential Strategy for Preventing and Managing Cardiovascular Disease. Nutrients. 2025; 17(1)DOI:10.3390/nu17010052. PMID:39796486. IF:5.000(Q1/2D).
01/01/2025 Effectiveness and safety of insulin glargine 300 U/mL in insulin-naïve individuals according to diabetes duration: Results from the REALI European pooled data analysis
Gourdy, P, Bonadonna, RC, Mauricio, D, Müller-Wieland, D, Mauquoi, C, Vera, C, Bonnemaire, M, Freemantle, N. Effectiveness and safety of insulin glargine 300 U/mL in insulin-naïve individuals according to diabetes duration: Results from the REALI European pooled data analysis. DIABETES OBESITY & METABOLISM. 2025; 27(1)DOI:10.1111/dom.16008. PMID:39420531. IF:5.700(Q1/2D).
01/01/2025 Ileal Predominance in Crohn's Disease Is Associated With Increased Intestinal Surgery and Biological Therapy Use, With Lower Treatment Persistence
Giordano, A, Pérez-Martínez, I, Gisbert, JP, Ricart, E, Martín-Arranz, MD, Mesonero, F, Parga, MLD, Rivero, M, Iglesias, E, Fernández-Prada, S, Calafat, M, Villarino, MTA, Turrión, MAD, Hernández-Camba, A, Lidón, RV, Carpio, D, Brunet, E, Moranta, FR, García, LA, Cuquerella, JT, Bermejo, F, Madero, L, Esteve, M, González-Muñoza, C, Martínez-Montiel, P, Huguet, JM, Calle, JLP, Rodríguez-Lago, I, Ausín, MS, Poyatos, RHL, García-Bosch, O, Marín, GS, Taxonera, C, Ponferrada-Diaz, A, Barreiro-de Acosta, M, Bujanda, L, Serra, RB, Ramos, L, Vera, I, Abizanda, ES, Piqueras, M, Gómez, CS, García-Sepulcre, MF, Arregui, MV, Murillo, NR, Llaó, J, Lucendo, AJ, Marín-Jiménez, I, Camps-Aler, B, Villafranca, CM, Ceballos, D, Ver, Y, Fernández-Salazar, LI, Alcaín, G, Valldosera, G, Andrés, PR, Martínez-Flores, C, Coronel, AF, Ginard, D, García, L, Gomez, IB, Argueelles-Arias, F, Miyashiro, EI, de la Piscina, PR, Villalba, LH, Notari, PA, Martínez-Pérez, TD, Fernández, H, Gilabert, P, Rosas, CM, Nos, P, Gil, JL, López, VMN, Muñoz, F, Palomares, MTDL, Lucio, AS, Merino, O, de Prado, IN, Leal, C, de Carpi, JM, Sánchez, LB, Arce, NM, Frago, S, Mateu, BB, Domènech, E, Planella, EG. Ileal Predominance in Crohn's Disease Is Associated With Increased Intestinal Surgery and Biological Therapy Use, With Lower Treatment Persistence. AMERICAN JOURNAL OF GASTROENTEROLOGY. 2025; 120(1)DOI:10.14309/ajg.0000000000003207. PMID:39745305. IF:7.600(Q1/1D).
01/01/2025 Vitamin D Supplementation Is Associated with Inflammation Amelioration and Cognitive Improvement in Decompensated Patients with Cirrhosis
Diaz-Ruiz, R, Poca, M, Roman, E, Panadero-Gomez, R, Cuyàs, B, Bañares, I, Morales, A, Puerto, M, Lopez-Esteban, R, Blazquez, E, Fernández-Castillo, M, Correa-Rocha, R, Rapado-Castro, M, Breton, I, Bañares, R, Soriano, G, Garcia-Martinez, R. Vitamin D Supplementation Is Associated with Inflammation Amelioration and Cognitive Improvement in Decompensated Patients with Cirrhosis. Nutrients. 2025; 17(2)DOI:10.3390/nu17020226. PMID:39861356. IF:5.000(Q1/2D).
01/01/2025 Real-World Experience of Imipenem-Relebactam Treatment as Salvage Therapy in Difficult-to-Treat Pseudomonas aeruginosa Infections (IMRECOR Study)
Machuca, I, Dominguez, A, Amaya, R, Arjona, C, Gracia-Ahufinger, I, Carralon, M, Giron, R, Gea, I, De Benito, N, Martin, A, Galan, F, Martinez, JA, Iglesias, R, Revuelto, J, Caston, JJ, Cano, A, Ruiz-Arabi, E, Martínez-Martínez, L, Torre-Cisneros, J. Real-World Experience of Imipenem-Relebactam Treatment as Salvage Therapy in Difficult-to-Treat Pseudomonas aeruginosa Infections (IMRECOR Study). Infectious Diseases and Therapy. 2025; 14(1)DOI:10.1007/s40121-024-01077-z. PMID:39612160. IF:5.300(Q1/2D).
01/01/2025 Cefiderocol for the Treatment of Infections by VIM-Type-Producing Gram-Negative Bacteria (vol 13, 874, 2024)
Kirkegaard-Biosca, C, del Barrio-Tofiño, E, Villamarín, M, Larrosa, N, Campany, D, González-López, JJ, Ferrer, R, Viñado, B, Doménech, L, Sellarès-Nadal, J, Escolà-Vergé, L, Fernández-Hidalgo, N, Los-Arcos, I. Cefiderocol for the Treatment of Infections by VIM-Type-Producing Gram-Negative Bacteria (vol 13, 874, 2024). Antibiotics-Basel. 2025; 14(1)DOI:10.3390/antibiotics14010004. PMID:39858394. IF:4.600(Q1/2D).
01/01/2025 EULAR recommendations for the treatment of systemic sclerosis: 2023 update
Del Galdo, F, Lescoat, A, Conaghan, PG, Bertoldo, E, Colic, J, Santiago, T, Suliman, YA, Matucci-Cerinic, M, Gabrielli, A, Distler, O, Hoffmann-Vold, AM, Castellví, I, Balbir-Gurman, A, Vonk, M, Ananyeva, L, Rednic, S, Tarasova, A, Ostojic, P, Boyadzhieva, V, El Aoufy, K, Farrington, S, Galetti, I, Denton, CP, Kowal-Bielecka, O, Mueller-Ladner, U, Allanore, Y. EULAR recommendations for the treatment of systemic sclerosis: 2023 update. ANNALS OF THE RHEUMATIC DISEASES. 2025; 84(1)DOI:10.1136/ard-2024-226430. PMID:39874231. IF:20.600(Q1/1D).